Precision medicine for paediatric oncology, revolutionising how children with cancer take medicines
| Reference number | |
| Coordinator | OnDosis AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | July 2024 - October 2024 |
| Status | Completed |
| Venture | Global cooperation 2024 |
| Call | Planning grant for international proposal 2024 |
Important results from the project
The purpose of the planning grant project was to create a winning proposal for the EIC Accelerator to revolutionize how children with cancer take their medications thereby saving many children´s lives. The collection of relevant information for compilation in the proposal was well accomplished. The submission of a full proposal at the cut-off in October was not met within the project´s time frame. Instead, we aim to use the results generated by this project for the next cut-off in March 2025.
Expected long term effects
The long-term expected effects consist of revolutionizing the way children with cancer take their medicines and thereby being able to save many children´s lives.
Approach and implementation
The project consisted of gathering information about market conditions, patient needs, and healthcare providers´ needs as well as clarifying the regulatory conditions, and submitting short and long proposals. This was carried out in 4 work packages that ran in parallel. Overall, the planning and implementation have worked very well, even if the main goal of submitting a full proposal was not reached within the project time.